Skorpios Trust - Apr 17, 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
10%+ Owner
Signature
/s/ Androulla Papadopoulou, Authorized Signatory on behalf of Skorpios Trust
Stock symbol
STOK
Transactions as of
Apr 17, 2024
Transactions value $
-$41,760,000
Form type
4
Date filed
4/18/2024, 04:16 PM
Previous filing
Dec 5, 2022
Next filing
Sep 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Sale -$41.8M -3.6M -24.92% $11.60 10.8M Apr 17, 2024 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Blue Horizon Enterprise Ltd. ("Blue Horizon") is the direct owner of 6,905,121 shares of the issuer's common stock and Ezbon International Limited ("Ezbon") is the direct owner of 3,938,560 shares of the issuer's common stock. Skorpios Trust ("Skorpios") is the sole owner of each of Blue Horizon and Ezbon. Montrago Trustees Limited ("Montrago Trustees") is the corporate trustee of Skorpios Trust. Each of Blue Horizon and Ezbon disclaim beneficial ownership of the shares of the issuer's common stock held by the other, and each of Skorpios Trust and Montrago Trustees disclaim beneficial ownership of the issuer's securities except to the extent of their pecuniary interest therein.